Genetic predisposition for beta cell fragility underlies type 1 and type 2 diabetes
James Dooley(VIB-KU Leuven Center for Cancer Biology), Lei Tian(VIB-KU Leuven Center for Cancer Biology), Susann Schönefeldt(VIB-KU Leuven Center for Cancer Biology), Viviane Delghingaro‐Augusto(Australian National University), Josselyn E. Garcia‐Perez(VIB-KU Leuven Center for Cancer Biology), Emanuela Pasciuto(VIB-KU Leuven Center for Cancer Biology), Daniele Di Marino(Università della Svizzera italiana), Edward J Carr(Babraham Institute), Nikolay Oskolkov(Lund University), Valeriya Lyssenko(Steno Diabetes Centers), Dean Franckaert(VIB-KU Leuven Center for Cancer Biology), Vasiliki Lagou(VIB-KU Leuven Center for Cancer Biology), Lut Overbergh(KU Leuven), Jonathan Vandenbussche(Ghent University), Joke Allemeersch(KU Leuven), Geneviève Chabot‐Roy(Hôpital Maisonneuve-Rosemont), Jane E. Dahlstrom(Australian National University), D. Ross Laybutt(Garvan Institute of Medical Research), Nikolai Petrovsky(Flinders University), Luis Socha(Australian National University), Kris Gevaert(Ghent University), Anton M. Jetten(National Institutes of Health), Diether Lambrechts(KU Leuven), Michelle A. Linterman(Babraham Institute), Christopher C. Goodnow(Garvan Institute of Medical Research), Christopher J. Nolan(Australian National University), Sylvie Lesage(Hôpital Maisonneuve-Rosemont), Susan Schlenner(VIB-KU Leuven Center for Cancer Biology), Adrian Liston(VIB-KU Leuven Center for Cancer Biology)
Cited by 148
Abstract
Related Papers
No related papers found
Powered by citation graph analysis